Federal Register / Vol. 87, No. 33 / Thursday, February 17, 2022 / Notices 9101 

companies while maintaining the 

integrity of the passport application 

process. 

Methodology 

This form is used to track the 

processing of passport applications and 

other documents delivered in bulk to 

passport agencies by private courier 

companies. Courier employees are asked 

to attach the form onto sealed envelopes 

or packages containing passport 

applications and other documents 

which they deliver in bulk to designated 

drop-off facilities at one of fourteen 

passport agencies for processing. A PDF 

fillable form will be available to 

download from https://eforms.state.gov. 

Kevin E. Bryant, 

Deputy Director, Office of Directives 

Management, Department of State. 

[FR Doc. 2022–03446 Filed 2–16–22; 8:45 am] 

BILLING CODE 4710–06–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2022–0026] 

Qualification of Drivers; Exemption 

Applications; Implantable Cardioverter 

Defibrillators (ICDs) 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), Department 

of Transportation (DOT). 

ACTION: Notice of applications for 

exemption; request for comments. 

SUMMARY: FMCSA announces receipt of 

applications from two individuals for an 

exemption from the prohibition in the 

Federal Motor Carrier Safety 

Regulations (FMCSRs) against operation 

of a commercial motor vehicle (CMV) by 

persons with a current clinical diagnosis 

of myocardial infarction, angina 

pectoris, coronary insufficiency, 

thrombosis, or any other cardiovascular 

disease of a variety known to be 

accompanied by syncope (transient loss 

of consciousness), dyspnea (shortness of 

breath), collapse, or congestive heart 

failure. If granted, the exemptions 

would enable these individuals with 

ICDs to operate CMVs in interstate 

commerce. 

DATES: Comments must be received on 

or before March 21, 2022. 

ADDRESSES: You may submit comments 

identified by the Federal Docket 

Management System (FDMS) Docket ID 

FMCSA–2022–0026 using any of the 

following methods: 

• Federal eRulemaking Portal: Go to 

www.regulations.gov/, insert the docket 

number, FMCSA–2022–0026, in the 

keyword box, and click ‘‘Search.’’ Next, 

sort the results by ‘‘Posted (NewerOlder),’’ choose the first notice listed, 

and click on the ‘‘Comment’’ button. 

Follow the online instructions for 

submitting comments. 

• Mail: Dockets Operations; U.S. 

Department of Transportation, 1200 

New Jersey Avenue SE, West Building 

Ground Floor, Room W12–140, 

Washington, DC 20590–0001. 

• Hand Delivery: West Building 

Ground Floor, Room W12–140, 1200 

New Jersey Avenue SE, Washington, 

DC, between 9 a.m. and 5 p.m., ET, 

Monday through Friday, except Federal 

Holidays. 

• Fax: (202) 493–2251. 

To avoid duplication, please use only 

one of these four methods. See the 

‘‘Public Participation’’ portion of the 

SUPPLEMENTARY INFORMATION section for 

instructions on submitting comments. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Christine A. Hydock, Chief, Medical 

Programs Division, (202) 366–4001, 

fmcsamedical@dot.gov, FMCSA, DOT, 

1200 New Jersey Avenue SE, Room 

W64–224, Washington, DC 20590–0001. 

Office hours are from 8:30 a.m. to 5 

p.m., ET, Monday through Friday, 

except Federal holidays. If you have 

questions regarding viewing or 

submitting material to the docket, 

contact Dockets Operations, (202) 366– 

9826. 

SUPPLEMENTARY INFORMATION: 

I. Public Participation 

A. Submitting Comments 

If you submit a comment, please 

include the docket number for this 

notice (Docket No. FMCSA–2022–0026), 

indicate the specific section of this 

document to which each comment 

applies, and provide a reason for each 

suggestion or recommendation. You 

may submit your comments and 

material online or by fax, mail, or hand 

delivery, but please use only one of 

these means. FMCSA recommends that 

you include your name and a mailing 

address, an email address, or a phone 

number in the body of your document 

so that FMCSA can contact you if there 

are questions regarding your 

submission. 

To submit your comment online, go to 

www.regulations.gov, insert the docket 

number FMCSA–2022–0026 in the 

keyword box, and click ‘‘Search.’’ Next, 

sort the results by ‘‘Posted (NewerOlder),’’ choose the first notice listed, 

click the ‘‘Comment’’ button, and type 

your comment into the text box on the 

following screen. Choose whether you 

are submitting your comment as an 

individual or on behalf of a third party 

and then submit. 

If you submit your comments by mail 

or hand delivery, submit them in an 

unbound format, no larger than 81⁄2 by 

11 inches, suitable for copying and 

electronic filing. If you submit 

comments by mail and would like to 

know that they reached the facility, 

please enclose a stamped, self-addressed 

postcard or envelope. 

FMCSA will consider all comments 

and material received during the 

comment period. 

B. Viewing Comments 

To view comments go to 

www.regulations.gov. Insert the docket 

number, FMCSA–2022–0026, in the 

keyword box, and click ‘‘Search.’’ Next, 

sort the results by ‘‘Posted (NewerOlder),’’ choose the first notice listed, 

and click ‘‘Browse Comments.’’ If you 

do not have access to the internet, you 

may view the docket online by visiting 

Dockets Operations in Room W12–140 

on the ground floor of the DOT West 

Building, 1200 New Jersey Avenue SE, 

Washington, DC 20590–0001, between 9 

a.m. and 5 p.m., ET, Monday through 

Friday, except Federal holidays. To be 

sure someone is there to help you, 

please call (202) 366–9317 or (202) 366– 

9826 before visiting Dockets Operations. 

C. Privacy Act 

In accordance with 5 U.S.C. 553(c), 

DOT solicits comments from the public 

to better inform its regulatory process. 

DOT posts these comments, without 

edit, including any personal information 

the commenter provides, to 

www.regulations.gov, as described in 

the system of records notice (DOT/ALL– 

14 FDMS), which can be reviewed at 

www.transportation.gov/privacy. 

II. Background 

Under 49 U.S.C. 31136(e) and 

31315(b), FMCSA may grant an 

exemption from the FMCSRs for no 

longer than a 5-year period if it finds 

such exemption would likely achieve a 

level of safety that is equivalent to, or 

greater than, the level that would be 

achieved absent such exemption. The 

statute also allows the Agency to renew 

exemptions at the end of the 5-year 

period. FMCSA grants medical 

exemptions from the FMCSRs for a 2- 

year period to align with the maximum 

duration of a driver’s medical 

certification. 

The two individuals listed in this 

notice have requested an exemption 

from § 391.41(b)(4). Accordingly, the 

Agency will evaluate the qualifications 

of each applicant to determine whether 

granting the exemption will achieve the 


lotter on DSK11XQN23PROD with NOTICES1
9102 Federal Register / Vol. 87, No. 33 / Thursday, February 17, 2022 / Notices 

1These criteria may be found in 49 CFR part 391, 

Appendix A to Part 391—Medical Advisory 

Criteria, Section D. Cardiovascular: § 391.41(b)(4), 

paragraph 4, which is available on the internet at 

https://www.gpo.gov/fdsys/pkg/CFR-2015-title49- 

vol5/pdf/CFR-2015-title49-vol5-part391-appA.pdf. 

required level of safety mandated by 

statute. 

The physical qualification standard 

found in § 391.41(b)(4) states that a 

person is physically qualified to drive a 

CMV if that person has no current 

clinical diagnosis of myocardial 

infarction, angina pectoris, coronary 

insufficiency, thrombosis, or any other 

cardiovascular disease of a variety 

known to be accompanied by syncope, 

dyspnea, collapse, or congestive cardiac 

failure. 

In addition to the regulations, FMCSA 

has published advisory criteria 1 to 

assist medical examiners in determining 

whether drivers with certain medical 

conditions are qualified to operate a 

CMV in interstate commerce. The 

advisory criteria states that ICDs are 

disqualifying due to risk of syncope. 

III. Qualifications of Applicants 

Michael Bianculli 

Mr. Bianculli is a CMV driver in 

Massachusetts. A December 3, 2021, 

letter from Mr. Bianculli’s cardiologist 

reports that an ICD was implanted in 

September 2021, for primary 

prevention. His cardiologist reports that 

he has never had cardiac arrest or loss 

of consciousness, his ICD has never 

fired, his cardiac function is normal, 

and he has no symptoms attributed to 

his cardiac condition. 

Kelly Lemus 

Ms. Lemus is a CMV driver in the 

state of Washington. An April 1, 2021, 

letter from Ms. Lemus’ cardiologist 

reports that an ICD was implanted in 

November 2011, after recurrent episodes 

of syncope. No documentation of 

sustained arrhythmias or therapies have 

been delivered from the ICD since 

implantation. Ms. Lemus has routine 

scheduled follow ups with cardiology. 

IV. Request for Comments 

In accordance with 49 U.S.C. 31136(e) 

and 31315(b), FMCSA requests public 

comment from all interested persons on 

the exemption petitions described in 

this notice. We will consider all 

comments received before the close of 

business on the closing date indicated 

under the DATES section of the notice. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2022–03412 Filed 2–16–22; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Pipeline and Hazardous Materials 

Safety Administration 

[Docket No.: PHMSA–2022–0008; Notice No. 

2022–03] 

Hazardous Materials: Request for 

Comments on Issues Concerning 

International Atomic Energy Agency 

Regulations for the Safe Transport of 

Radioactive Materials 

AGENCY: Pipeline and Hazardous 

Materials Safety Administration 

(PHMSA), Department of Transportation 

(DOT). 

ACTION: Notice; request for comments. 

SUMMARY: PHMSA and the U.S. Nuclear 

Regulatory Commission are jointly 

seeking comments on issues concerning 

requirements in the International 

Atomic Energy Agency (IAEA) 

regulations for the safe transport of 

radioactive materials. The IAEA is 

considering revisions to their 

regulations as part of its periodic review 

cycle for a new edition. 

DATES: Submit comments by March 4, 

2022. Comments received after this date 

will be considered if it is practical to do 

so; however, we are only able to assure 

consideration for proposals received on 

or before this date. 

ADDRESSES: You may submit comments 

identified by the docket number 

(PHMSA–2022–0008) by any of the 

following methods: 

• Federal eRulemaking Portal: Go to 

http://www.regulations.gov. Follow the 

online instructions for submitting 

comments. 

• Fax: 1–202–493–2251. 

• Mail: Docket Operations, U.S. 

Department of Transportation, West 

Building, Ground Floor, Room W12– 

140, Routing Symbol M–30, 1200 New 

Jersey Avenue SE, Washington, DC 

20590. 

• Hand Delivery: To Docket 

Operations, Room W12–140 on the 

ground floor of the West Building, 1200 

New Jersey Avenue SE, Washington, DC 

20590, between 9 a.m. and 5 p.m., 

Monday through Friday, except federal 

holidays. 

Instructions: All submissions must 

include the agency name and docket 

number for this notice at the beginning 

of the comment. Note that all comments 

received will be posted without change 

to the docket management system, 

including any personal information 

provided. 

Docket: For access to the dockets to 

read background documents or 

comments received, go to http://

www.regulations.gov, or DOT’s Docket 

Operations Office (see ADDRESSES). 

Privacy Act: Anyone is able to search 

the electronic form of any written 

communications and comments 

received into any of our dockets by the 

name of the individual submitting the 

document (or signing the document, if 

submitted on behalf of an association, 

business, labor union, etc.). You may 

review DOT’s complete Privacy Act 

Statement in the Federal Register 

published on April 11, 2000 (65 FR 

19477) or you may visit http://

www.regulations.gov. 

Confidential Business Information 

(CBI): CBI is commercial or financial 

information that is both customarily and 

actually treated as private by its owner. 

Under the Freedom of Information Act 

(FOIA) (5 U.S.C. 552), CBI is exempt 

from public disclosure. If your 

comments responsive to this notice 

contain commercial or financial 

information that is customarily treated 

as private, that you actually treat as 

private, and that is relevant or 

responsive to this notice, it is important 

that you clearly designate the submitted 

comments as CBI. Please mark each 

page of your submission containing CBI 

as ‘‘PROPIN.’’ PHMSA will treat such 

marked submissions as confidential 

under the FOIA, and they will not be 

placed in the public docket of this 

notice. Submissions containing CBI 

should be sent to Rick Boyle, Sciences 

and Engineering Division, (202) 366– 

4545, Pipeline and Hazardous Materials 

Safety Administration, U.S. Department 

of Transportation, 1200 New Jersey 

Avenue SE, Washington, DC 20590– 

0001. Any commentary that PHMSA 

receives which is not specifically 

designated as CBI will be placed in the 

public docket for this notice. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Rick Boyle, Sciences and Engineering 

Division, (202) 366–4545, Pipeline and 

Hazardous Materials Safety 

Administration. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The International Atomic Energy 

Agency (IAEA) works with its Member 

States and multiple partners worldwide 

to promote safe, secure, and peaceful 

nuclear technologies. The IAEA 

established and maintains an 

international standard, Regulations for 

the Safe Transport of Radioactive 

Material (SSR–6 (Rev. 1)), to promote 

the safe and secure transportation of 

radioactive material. The IAEA 

periodically reviews and, as deemed 

appropriate, revises its regulations to 

reflect new information and 


lotter on DSK11XQN23PROD with NOTICES1